U.S. markets close in 2 hours 31 minutes
  • S&P 500

    4,399.14
    -20.01 (-0.45%)
     
  • Dow 30

    34,948.69
    -135.84 (-0.39%)
     
  • Nasdaq

    14,689.75
    -88.52 (-0.60%)
     
  • Russell 2000

    2,227.30
    -12.73 (-0.57%)
     
  • Crude Oil

    73.99
    +0.37 (+0.50%)
     
  • Gold

    1,818.50
    -17.30 (-0.94%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1864
    -0.0032 (-0.27%)
     
  • 10-Yr Bond

    1.2360
    -0.0330 (-2.60%)
     
  • GBP/USD

    1.3900
    -0.0057 (-0.41%)
     
  • USD/JPY

    109.8200
    +0.3590 (+0.33%)
     
  • BTC-USD

    38,998.83
    -755.66 (-1.90%)
     
  • CMC Crypto 200

    926.91
    -22.99 (-2.42%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

2 Biotech Stocks ARK Invest Bought in June

·4 min read
2 Biotech Stocks ARK Invest Bought in June

Over the past few years, Cathie Wood's ARK Invest group of exchange-traded funds have delivered impressive gains. ARK Invest's most successful fund over the past year, the ARK Genomic Revolution ETF (NYSEMKT: ARKG) has the best performer of the bunch with an incredible 80% gain over the past 12 months. On Jun. 3, 2021, the ARK Genomic Revolution ETF bought shares of these two clinical-stage biotechs.